Cargando…

Efficacy of Lanthanum Carbonate and Sevelamer Carbonate as Phosphate Binders in Chronic Kidney Disease—A Comparative Clinical Study

(1) Background: Hyperphosphatemia is correlated with an increased rate of mortality and morbidity due to cardiovascular diseases in chronic kidney disease (CKD) patients. It can be improved by restricting dietary intake of phosphate and oral phosphate binders, such as lanthanum carbonate and sevelam...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nain, Parminder, Nayak, Narendra, Maj, Mary C., Singh, Rohit Kumar, Kaur, Jaspreet, Jeong, Yujin, Maity, Sabyasachi, Nath, Reetuparna, Hilgers, Robert H., Nauhria, Shreya, Nauhria, Samal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9960578/ https://www.ncbi.nlm.nih.gov/pubmed/36827665 http://dx.doi.org/10.3390/pharmacy11010027

Ejemplares similares

A Review and Meta-Analysis of the Prevalence and Health Impact of Polycystic Ovary Syndrome Among Medical and Dental Students
por: Coffin, Tamara, et al.
Publicado: (2023)

Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Colorectal Carcinoma: A Potential Area of Focus for Future Diagnostics
por: Kaur, Simrandeep, et al.
Publicado: (2022)

Academic and Social Impact of Menstrual Disturbances in Female Medical Students: A Systematic Review and Meta-Analysis
por: Maity, Sabyasachi, et al.
Publicado: (2022)

Effectiveness of Empagliflozin With Vitamin D Supplementation in Peripheral Neuropathy in Type 2 Diabetic Patients
por: Mehta, Sanjana, et al.
Publicado: (2021)

Virtual Versus Light Microscopy Usage among Students: A Systematic Review and Meta-Analytic Evidence in Medical Education
por: Maity, Sabyasachi, et al.
Publicado: (2023)

The effect of sevelamer carbonate and lanthanum carbonate on the pharmacokinetics of oral calcitriol
por: Pierce, David, et al.
Publicado: (2011)

Pharmacology of the Phosphate Binder, Lanthanum Carbonate
por: Damment, Stephen JP
Publicado: (2011)

A meta-analysis of phosphate binders lanthanum carbonate versus sevelamer hydrochloride in patients with end-stage renal disease undergoing hemodialysis
por: Zhou, Tianbiao, et al.
Publicado: (2018)

Correction of metabolic acidosis after conversion from sevelamer hydrochloride to lanthanum carbonate
por: Lindley, Elizabeth, et al.
Publicado: (2008)

Utility of Direct Immunofluorescence in Cutaneous Autoimmune Bullous Disorders
por: Brar, Arika, et al.
Publicado: (2021)

Effects of Sucroferric Oxyhydroxide Compared to Lanthanum Carbonate and Sevelamer Carbonate on Phosphate Homeostasis and Vascular Calcifications in a Rat Model of Chronic Kidney Failure
por: Phan, Olivier, et al.
Publicado: (2015)

Different Effect of Lanthanum Carbonate and Sevelamer Hydrochloride on Calcium Balance in Patients with Moderate to Advanced Chronic Kidney Disease
por: Makowka, Agnieszka, et al.
Publicado: (2021)

Sevelamer Carbonate Crystal-Induced Colitis
por: Lai, T., et al.
Publicado: (2020)

Comparison of Sevelamer and Calcium Carbonate in Prevention of Hypomagnesemia in Hemodialysis Patients
por: Jandaghi, Elahe, et al.
Publicado: (2021)

Sevelamer carbonate increases serum bicarbonate in pediatric dialysis patients
por: Gonzalez, Elsa, et al.
Publicado: (2010)

Encephalopathy caused by lanthanum carbonate
por: Fraile, Pilar, et al.
Publicado: (2011)

A randomized, crossover design study of sevelamer carbonate powder and sevelamer hydrochloride tablets in chronic kidney disease patients on haemodialysis
por: Fan, Stanley, et al.
Publicado: (2009)

Development and Validation of a Gas Chromatography Method for the Trace Level Determination of Allylamine in Sevelamer Hydrochloride and Sevelamer Carbonate Drug Substances
por: Kadiyala, Raju V. S. N., et al.
Publicado: (2014)

Sevelamer as a phosphate binder in adult hemodialysis patients: an evidence-based review of its therapeutic value
por: Nadin, Carole
Publicado: (2005)

Sevelamer carbonate in the treatment of hyperphosphatemia in patients with chronic kidney disease on hemodialysis
por: Savica, Vincenzo, et al.
Publicado: (2008)

Sevelamer carbonate experience in Indian end stage renal disease patients
por: Abraham, G., et al.
Publicado: (2012)

Evaluation of calcium acetate/magnesium carbonate as a phosphate binder compared with sevelamer hydrochloride in haemodialysis patients: a controlled randomized study (CALMAG study) assessing efficacy and tolerability
por: de Francisco, Angel L.M., et al.
Publicado: (2010)

Phosphate binding therapy in dialysis patients: focus on lanthanum carbonate
por: Mohammed, Ismail A, et al.
Publicado: (2008)

Lanthanum carbonate hydrate causes artifacts on ultrasound
por: Kuroiwa, Kaori K., et al.
Publicado: (2015)

Diagnosis: Benign bowel distribution of lanthanum carbonate
por: Wu, Hsin-Chi, et al.
Publicado: (2008)

Successful Treatment of Tumoral Calcinosis by Lanthanum Carbonate
por: Hsiao, Ching-Chung, et al.
Publicado: (2018)

Lanthanum Carbonate Opacities—A Systematic Review
por: Kampmann, Jan, et al.
Publicado: (2022)

Gastric lanthanosis (lanthanum deposition) in an immunosuppressed patient that discontinued lanthanum carbonate seven years ago
por: Ullmann, Joana M., et al.
Publicado: (2021)

Endometriosis and irritable bowel syndrome: A systematic review and meta-analyses
por: Nabi, Michelle Y., et al.
Publicado: (2022)

Lanthanum carbonate: safety data after 10 years
por: Hutchison, Alastair J, et al.
Publicado: (2016)

The effect of lanthanum carbonate on calciprotein particles in hemodialysis patients
por: Nakamura, Kimihiko, et al.
Publicado: (2019)

Sevelamer carbonate reduces the risk of hypomagnesemia in hemodialysis-requiring end-stage renal disease patients
por: Rosa-Diez, Guillermo, et al.
Publicado: (2016)

Lanthanum Carbonate Reduces Urine Phosphorus Excretion: Evidence of High-Capacity Phosphate Binding
por: Pennick, Michael, et al.
Publicado: (2012)

Synchronous, efficient and fast removal of phosphate and organic matter by carbon-coated lanthanum nanorods
por: Zhang, Xintong, et al.
Publicado: (2018)

Quantitative Visualization of Lanthanum Accumulation in Lanthanum Carbonate-Administered Human Stomach Tissues Using Mass Spectrometry Imaging
por: Shimma, Shuichi, et al.
Publicado: (2020)

The management of hyperphosphatemia by lanthanum carbonate in chronic kidney disease patients
por: Shigematsu, Takashi, et al.
Publicado: (2012)

Lanthanum carbonate is not associated with QT interval modification in hemodialysis patients
por: Di Iorio, Biagio, et al.
Publicado: (2010)

Encephalopathy in a dialysis patient treated with lanthanum carbonate (LC)
por: Brancaccio, Diego, et al.
Publicado: (2012)

The Risk of Mistaking Intestinal Lanthanum Carbonate for Intestinal Bleeding on CT
por: Salerno, D., et al.
Publicado: (2015)

All that glitters is not gold: A case of lanthanum carbonate aspiration
por: Paranji, Suchitra, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_dr04qk9e8rg9m5qr3s3ig69ocb